Navigation Links
FDA Approves AstraZeneca's Seroquel(R) for Maintenance Treatment in Bipolar Disorder
Date:5/14/2008

WILMINGTON, Del., May 14 /PRNewswire-FirstCall/ -- AstraZeneca (NYSE: AZN) today announced that the U.S. Food and Drug Administration (FDA) has approved SEROQUEL(R) (quetiapine fumarate tablets) for the maintenance treatment of patients with bipolar I disorder, as adjunct therapy to lithium or divalproex. SEROQUEL is approved by the FDA for the treatment of schizophrenia, and is also the only single agent approved by the FDA for the treatment of both depressive episodes in bipolar disorder and acute manic episodes associated with bipolar I disorder. (1,2)

Considered one of the most severe forms of mental illness, bipolar disorder currently affects about 8 million adults in the U.S.(3-5) Bipolar I disorder is a lifelong psychiatric condition characterized by manic or mixed mood episodes, interspersed with major depressive episodes. (6) It is estimated that 0.4 percent to 1.6 percent of individuals will develop bipolar I disorder in their lifetime. (6)

"This new indication for SEROQUEL marks an important milestone in the treatment of bipolar I disorder because it provides patients with another option over the long-term. In fact, despite the number of currently available treatments, many patients with bipolar I disorder do not receive effective therapy and some 20 to 30 percent of patients continue to display residual mood symptoms of bipolar I disorder," said Mark Scott, Executive Director, Clinical Development, SEROQUEL. "The studies showed that SEROQUEL, with lithium or divalproex, can provide clinicians with a safe and effective long-term treatment option that reduced the risk of relapse of both manic and depressive mood events in bipolar I disorder."

The FDA approval was based on two multicenter, randomized, double-blind, placebo-controlled clinical trials that evaluated SEROQUEL when used as an adjunct therapy to lithium or divalproex in the maintenance treatment of adult patients with bipolar I disorder (n=703, n=623 respectively). (7
'/>"/>

SOURCE AstraZeneca
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. FDA Approves NOVO NORDISKs NovoSeven(R) RT (Coagulation Factor VIIa [Recombinant] Room Temperature Stable) for Hemophilia Patients With Inhibitors
2. FDA Approves Taclonex Scalp(R) - Once Daily Therapy for Treatment of Moderate to Severe Scalp Psoriasis
3. FDA Approves Health Claim for Brown Rice
4. FDA Approves Strattera(R) for Maintenance of ADHD in Children and Adolescents
5. FDA approves HeartMate II mechanical heart pump for heart-failure patients
6. FDA Approves Advair(R) 250/50 for Reduction of Exacerbations in Patients With COPD
7. FDA Approves New Once-a-Month Dose of Actonel for Postmenopausal Osteoporosis
8. FDA approves VYVANSE, first and only once-daily prodrug stimulant to treat ADHD in adults
9. FDA APPROVES ROTARIX(R) [Rotavirus Vaccine, live, oral], THE FIRST VACCINE LICENSED TO COMPLETE THE ROTAVIRUS IMMUNIZATION SERIES BY FOUR MONTHS OF AGE
10. House Overwhelmingly Approves Renewal and Tripling of Successful U.S. Global AIDS Prevention Effort
11. VeriPrime Approves New Best Practices for Beef Production
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/12/2014)... 2014 “Critical Care Therapeutics in ... Late-Stage Four-Factor PCCs and Recombinant Products to Drive ... care market in the US, UK, France, Germany, ... an estimation of market size for 2013, along ... care indications that are being treated using the ...
(Date:7/12/2014)... July 12, 2014 Utah Valley Entrepreneurial ... startups, with awards being bestowed to companies in revenue, ... outstanding entrepreneur community with recognition for new ideas as ... with incoming revenue. , 25 Under 5 highlights outstanding ... that are under 5 years old. Award recipients were ...
(Date:7/12/2014)... Texas (PRWEB) July 12, 2014 ... Breastfeeding Made Simple as a valuable new resource for ... roughly two-thirds of American women work away from their ... sources touting the benefits of breastfeeding, but often feel ... to nurse their babies. With its evidence-based insights, and ...
(Date:7/12/2014)... CA (PRWEB) July 12, 2014 ... power score of 4.1 out of 5. This ... that have been underpinning buyer negotiation power over ... procurement analyst Anna Son, “during the period, surging ... rising costs associated with new product development, have ...
(Date:7/12/2014)... Ladies, it doesn't matter what your budget is, ... looking for an affordable gown can visit Discount-Dress.com ... get their dream items. Recently, the company has announced its ... Along with that, it is also providing great discounts for ... the deadline of this promotion is July 29, 2014. ...
Breaking Medicine News(10 mins):Health News:Critical Care Therapeutics in Major Developed Market is Expected to Grow at a CAGR of 4.7% to $2.5 Billion in 2019 2Health News:Critical Care Therapeutics in Major Developed Market is Expected to Grow at a CAGR of 4.7% to $2.5 Billion in 2019 3Health News:Critical Care Therapeutics in Major Developed Market is Expected to Grow at a CAGR of 4.7% to $2.5 Billion in 2019 4Health News:Critical Care Therapeutics in Major Developed Market is Expected to Grow at a CAGR of 4.7% to $2.5 Billion in 2019 5Health News:Critical Care Therapeutics in Major Developed Market is Expected to Grow at a CAGR of 4.7% to $2.5 Billion in 2019 6Health News:SquareHook is Recognized for UVEF 25 Businesses Under 5 Years-Watch Out 2Health News:Praeclarus Press Announces the Release of Working and Breastfeeding Made Simple by Nancy Mohrbacher, A Much Needed Resource For Today's Working Mothers 2Health News:Floor-Grade Instruments Procurement Category Market Research Report from IBISWorld has Been Updated 2Health News:Floor-Grade Instruments Procurement Category Market Research Report from IBISWorld has Been Updated 3Health News:Floor-Grade Instruments Procurement Category Market Research Report from IBISWorld has Been Updated 4Health News:Worldwide Brides-to-be: It Is Time To Show Your Beauty By Wearing A Trendy Summer Short Wedding Dress From Discount-Dress.com 2
... YORK (June 15, 2011) -- Ever since the Institute of ... 1999, significant attention has been paid to improving patient safety ... events, including major injury and even death, occur in private ... study -- the first of its kind -- researchers at ...
... , TUESDAY, June 14 (HealthDay News) -- Patients ... if they have elevated levels of a certain hormone, a ... (FGF-23) regulates phosphorus metabolism. It was known that levels of ... of the hormone are associated with increased risk of death ...
... where open space is plentiful and there is often ... rural elders are far more likely to be overweight ... suburban counterparts, according to a new policy brief from ... All three conditions are risk factors for heart ...
... growth is blocked by drugs targeting that path, the malignancy ... around the roadblock. In a study at UCLA,s Jonsson ... of prostate cancer was treated with conventional hormone ablation therapy ... growth of the tumor the cancer was able to ...
... Day this Sunday is a chance to recognize dads for putting ... up on the way to adulthood. But a new study ... dad,s job as a role model actually is. The study, ... and Environmentally Controlled Sibling Study," is due to be published in ...
... By Jenifer Goodwin HealthDay Reporter , TUESDAY, June ... they might also sleep better, according to researchers who say ... sleeptime, may help treat insomnia. Previous research has shown ... have a higher brain metabolism in the frontal lobes, which ...
Cached Medicine News:Health News:JAMA study points to patient safety risks outside hospital walls 2Health News:JAMA study points to patient safety risks outside hospital walls 3Health News:Hormone Linked to Death Risk in Those With Early Kidney Disease 2Health News:Out of reach? Rural elders have highest rates of obesity, diabetes, heart disease 2Health News:Prostate cancer gets around hormone therapy by activating a survival cell signaling pathway 2Health News:Prostate cancer gets around hormone therapy by activating a survival cell signaling pathway 3Health News:Note to dads: Good parenting makes a difference 2Health News:Sleeptime Head-Cooling Cap Eases Insomnia, Study Finds 2Health News:Sleeptime Head-Cooling Cap Eases Insomnia, Study Finds 3
(Date:7/10/2014)... MILPITAS, Calif. , July 10, 2014 ... a leader in advanced memory and analog IC solutions, ... call on Thursday, July 24, 2014, at 7:00 a.m. ... Company,s financial results for the fiscal 2014 third quarter ... conference call via telephone, dial 1-888-556-4997 before 6:50 a.m. ...
(Date:7/10/2014)... , July 10, 2014   Ventana Medical ... today announced it has entered into an agreement with ... operates as EMD Serono in the United ... to collaborate with Merck KGaA,s biopharmaceutical division on the ... an undisclosed target using Ventana,s proprietary diagnostic assays. In ...
(Date:1/15/2014)... 2014 Sono-Tek Corporation (OTC BB: SOTK) today announced sales ... compared to sales of $2,202,000 for the prior year period, ... has also shown growth over the preceding quarter,s sales, continuing ... fiscal year. Markets that experienced sales increases over the prior ...
Breaking Medicine Technology:Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 2Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 3Sono-Tek Announces Third Quarter Results 2Sono-Tek Announces Third Quarter Results 3Sono-Tek Announces Third Quarter Results 4
... Volcano Corporation (Nasdaq: VOLC ) announced today the completion of the first ... performed in seven centers within the United States . Commercial launch of Eagle ... , , ... , , ...
... , SAN DIEGO , May 20 ... announced today that the U.S. Patent and Trademark Office has ... microfluidic device. U.S. patent #7,695,956 entitled "Device for Cell Separation ... to isolate cells from a bodily fluid using a flow ...
Cached Medicine Technology:Physicians Cite Positive First Clinical Experience with Volcano's Eagle Eye® Platinum Digital IVUS Catheter 2Physicians Cite Positive First Clinical Experience with Volcano's Eagle Eye® Platinum Digital IVUS Catheter 3Physicians Cite Positive First Clinical Experience with Volcano's Eagle Eye® Platinum Digital IVUS Catheter 4Biocept, Inc. Announces Issuance of Patent for its Microfluidic Technology 2
The three point staple, used for valgus tibial osteotomy, is easy and quick to fit, with a compact size compared with other existing systems....
... design of the osteotomy staples is quite similar to ... are the inner position of the anti recoil contours ... staples). There are 3 kinds of staples: ... and the staples can have 3 different widths: 20mm, ...
A new generation of ORTHOMED S.A. fixation staples, manufactured from cobalt-chromium alloy: tried and test strength and tolerance...
... Sterile Barium Sulfate USP is specifically ... consistent imaging capabilities for todays medical ... minimally invasive surgery. Comprised of a ... even diffusion of sterile barium, resulting ...
Medicine Products: